Keyphrases
Denmark
45%
HIV Patients
42%
Antiretroviral Therapy
41%
People Living with HIV (PLHIV)
40%
Confidence Interval
37%
Plasmodium Falciparum
35%
COVID-19
30%
National Cohort Study
26%
AIDS/HIV
25%
Europe
22%
Malaria
20%
HIV Infection
19%
Human Immunodeficiency Virus Type 1 (HIV-1)
19%
HIV-positive
17%
Risk Factors
17%
CD4 Count
17%
Skeletal muscle
17%
Interleukin-6
16%
Tuberculosis
15%
Cystic Fibrosis
14%
PfEMP1
13%
Incidence Rate
13%
Combined Antiretroviral Therapy (cART)
13%
VAR2CSA
12%
Hepatitis C Virus
12%
Type 2 Diabetes Mellitus (T2DM)
12%
Infected Erythrocytes
10%
Copenhagen
10%
Comorbidity
10%
Donor-acceptor
9%
Inflammation
9%
Tanzania
9%
Cardiovascular Disease
9%
Randomized Controlled Trial
9%
Cardiovascular Risk
9%
Hazard Ratio
8%
Insulin Resistance
8%
Viral Load
8%
Highly Active Antiretroviral Therapy (HAART)
8%
Infected Patients
8%
During Exercise
8%
Rheumatoid Arthritis
7%
Prospective Cohort Study
7%
Clinical Outcomes
7%
EuroSIDA
7%
Vaccination
7%
Human Skeletal muscle
7%
Placental Malaria
7%
D Study
7%
Antibody Response
7%
Randomized Trial
7%
Falciparum Malaria
7%
High Risk
7%
All-cause Mortality
6%
Malaria Vaccine
6%
Odds Ratio
6%
Mycobacterium Tuberculosis (M. tb)
6%
Tumor Necrosis Factor-α
6%
Systemic Lupus Erythematosus
6%
Pregnant Women
6%
Infected Individual
6%
Non-AIDS Comorbidities
6%
Myocardial Infarction
6%
Adverse Events
6%
Non-associated
6%
HIV RNA
6%
Hospitalized Patients
5%
Virological Failure
5%
Diabetes
5%
Hospitalization
5%
Exercise Training
5%
Infectious Diseases
5%
Mortality Rate
5%
Polymorphism
5%
Insulin Sensitivity
5%
Hepatitis C
5%
Nave
5%
Greenland
5%
Immune Response
5%
Chronic Kidney Disease
5%
Healthy Controls
5%
Antiviral Drugs
5%
Human Immunodeficiency Virus Infection
5%
Antiretroviral Therapy Initiation
5%
Patients with COVID-19
5%
Eastern Europe
5%
Exercise-induced
5%
Chronic Obstructive Pulmonary Disease
5%
Sub-Saharan Africa
5%
Solid Organ Transplant Recipients
5%
Body Mass Index
5%
Chondroitin Sulfate
5%
Meningitis
5%
Severe Malaria
5%
Cytomegalovirus
5%
Healthy Individuals
5%
Ghana
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Infection
37%
Cohort Analysis
35%
Antiretroviral Therapy
26%
Disease
20%
COVID-19
19%
Skeletal Muscle
16%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Prevalence
14%
Human Immunodeficiency Virus Infection
11%
Malignant Neoplasm
10%
Cystic Fibrosis
10%
Symptom
10%
Cardiovascular Disease
8%
Maturity Onset Diabetes of the Young
8%
Hepatitis C Virus
8%
Cross Sectional Study
8%
Hazard Ratio
7%
Odds Ratio
7%
Population
7%
Diagnosis
7%
Biological Marker
6%
Prospective Cohort Study
6%
Diabetes
6%
Cell Count
6%
Randomized Controlled Trial
6%
Hepatitis C
6%
Transplantation
5%
Adverse Event
5%
Insulin Resistance
5%
Intensive Care Unit
5%
Body Mass Index
5%
Systematic Review
5%
Diabetes Mellitus
5%
Arm
5%